Show simple item record

dc.creatorHouseholder, Michael
dc.creatorSolano López, Ana Laura
dc.creatorMuñoz Rojas, Derby
dc.creatorRivera, Suzanne M.
dc.date.accessioned2022-01-06T20:08:26Z
dc.date.available2022-01-06T20:08:26Z
dc.date.issued2019
dc.identifier.citationhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eahr.500004
dc.identifier.issn2578-2363
dc.identifier.urihttps://hdl.handle.net/10669/85524
dc.description.abstractCosta Rica is a small developing nation in Central America with a well-regarded universal health care system and a strong human rights tradition. In the latter part of the twentieth century, it became a popular site for clinical trials funded by multinational pharmaceutical companies. In light of concerns about ineffective oversight and alleged research abuses, the Constitutional Chamber of the Supreme Court passed a moratorium on all biomedical studies involving humans. This moratorium was in place between 2010 and 2014, when the Legislative Assembly passed a new national law to protect participants’ rights and welfare. This case study reviews the history of human research protections in Costa Rica and provides recommendations for how Costa Rica can move forward responsibly as a leader in human research for the region.es_ES
dc.language.isoenges_ES
dc.sourceEthics and Human Research 41(1), pp. 32-40es_ES
dc.subjectHuman subjects researches_ES
dc.subjectCosta Ricaes_ES
dc.subjectResearch moratoriumes_ES
dc.subjectHuman research ethicses_ES
dc.subjectBiomedical researches_ES
dc.titleReviving Human Research in Costa Rica. Ethics and Human Researches_ES
dc.typeartículo científico
dc.identifier.doi10.1002/eahr.500004
dc.description.procedenceUCR::Vicerrectoría de Docencia::Salud::Facultad de Medicina::Escuela de Enfermeríaes_ES


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record